Rosuvastatin prevents pressure overload-induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats

被引:17
作者
Xu, Xue [1 ]
Zhang, Lei [2 ]
Liang, Jiangjiu [1 ]
机构
[1] Shandong Univ, Dept Hlth Care, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Dept Orthoped, Shandong Prov Qianfoshan Hosp, Affiliated Hosp, Jinan 250014, Shandong, Peoples R China
关键词
rosuvastatin; myocardial hypertrophy; pressure overload; Akt; extracellular signal-regulated kinase 1/2; GATA binding protein 4; INDUCED CARDIAC-HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; TRANSCRIPTION FACTOR GATA4; IN-VIVO; REGULATED KINASE; HEART-FAILURE; STRESS; ACTIVATION; REGRESSION; STATINS;
D O I
10.3892/mmr.2013.1548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pressure overload-induced myocardial hypertrophy is associated with a poor prognosis in humans and contributes to the development of cardiac arrhythmias, diastolic dysfunction and ultimate congestive heart failure. 3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors, also known as statins, have been previously shown to induce regression of myocardial hypertrophy in aortic banding models. However, there is limited knowledge regarding the underlying molecular mechanisms. Therefore, we hypothesized that the myocardial hypertrophy-related signaling pathways protein kinase B (Akt), extracellular signal-regulated kinases 1 or 2 (ERK1/2) and GATA binding protein 4 (GATA4) activation pathways constitute targets of rosuvastatin (RSV). Therefore, the above-mentioned activation pathways were hypothesized to be involved in the regression of pressure overload-induced myocardial hypertrophy treated by RSV. Twenty-eight Wistar rats were randomly allocated into 4 groups: the sham operation-vehicle (SH-V), abdominal aortic constriction-vehicle (AAC-V), abdominal aortic constriction-RSV 10 mg/kg/day (AAC-LO) and the abdominal aortic constriction-RSV 20 mg/kg/day (AAC-HI) group. Following the establishment of the abdominal aorta constriction model, we investigated the effect of RSV, a new hydrophilic statin, on abdominal aortic constriction-induced myocardial hypertrophy as well as the underlying intercellular signaling pathways after 5 days and 4 weeks of drug intervention. Moreover, echocardiographic features and the left ventricular weight to final body weight ratio (LVW/BW) were determined. Cross-sectional areas (CSAs) of cardiomyocytes were assessed by hematoxylin and eosin (H&E) staining. Atrial natriuretic factor (ANF), beta-myosin heavy chain (beta-MHC) and peroxisome proliferator-activated receptor alpha (PPAR alpha) messenger RNA (mRNA) expression was assessed using RT-PCR. The phosphorylation of Akt, ERK1/2 and GATA4 were also examined using western blot analysis. Our results showed that RSV significantly attenuates pressure overload-induced myocardial hypertrophy by preventing myocardial hypertrophy-related activation of Akt, ERK1/2 and GATA4 signaling pathways.
引用
收藏
页码:385 / 392
页数:8
相关论文
共 33 条
  • [1] Clinical significance of pleiotropic effects of statins: Lipid reduction and beyond
    Auer, J
    Berent, R
    Weber, T
    Eber, B
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (20) : 1831 - 1850
  • [2] AKT signalling in the failing heart
    Chaanine, Antoine H.
    Hajjar, Roger J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (08) : 825 - 829
  • [3] Effect of Rosuvastatin on Cardiac Remodeling, Function, and Progression to Heart Failure in Hypertensive Heart With Established Left Ventricular Hypertrophy
    Chang, Sung-A
    Kim, Yong-Jin
    Lee, Hye-Won
    Kim, Dae-Hee
    Kim, Hyung-Kwan
    Chang, Hyuk-Jae
    Sohn, Dae-Won
    Oh, Byung-Hee
    Park, Young-Bae
    [J]. HYPERTENSION, 2009, 54 (03) : 591 - U278
  • [4] Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh
    Choi, Eui-Young
    Chang, Woochul
    Lim, Soyeon
    Song, Byeong-Wook
    Cha, Min-Ji
    Kim, Hye-Jung
    Choi, Eunju
    Jang, Yangsoo
    Chung, Namsik
    Hwang, Ki-Chul
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 56 - 62
  • [5] Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice
    Condorelli, G
    Drusco, A
    Stassi, G
    Bellacosa, A
    Roncarati, R
    Iaccarino, G
    Russo, MA
    Gu, YS
    Dalton, N
    Chung, C
    Latronico, MVG
    Napoli, C
    Sadoshima, J
    Croce, CM
    Ross, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) : 12333 - 12338
  • [6] Cardiac overexpression of a Gq inhibitor blocks induction of extracellular signal-regulated kinase and cJun NH2-terminal kinase activity in in vivo pressure overload
    Esposito, G
    Prasad, SVN
    Rapacciuolo, A
    Mao, L
    Koch, WJ
    Rockman, HA
    [J]. CIRCULATION, 2001, 103 (10) : 1453 - 1458
  • [7] Fukumoto Y, 2001, CIRCULATION, V103, P993
  • [8] Rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases cardiac oxidative stress and remodeling in Ren2 transgenic rats
    Habibi, Javad
    Whaley-Connell, Adam
    Qazi, Mahnaz A.
    Hayden, Melvin R.
    Cooper, Shawna A.
    Tramontano, Anthony
    Thyfault, John
    Stump, Craig
    Ferrario, Carlos
    Muniyappa, Ranganath
    Sowers, James R.
    [J]. ENDOCRINOLOGY, 2007, 148 (05) : 2181 - 2188
  • [9] Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats
    Hong, Y
    Hui, SC
    Chan, TY
    Hou, JY
    [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2002, 30 (04): : 589 - 599
  • [10] Effects of Pitavastatin on Pressure Overload-Induced Heart Failure in Mice
    Kameda, Yoshihito
    Hasegawa, Hiroshi
    Kubota, Akihiko
    Tadokoro, Hiroyuki
    Kobayashi, Yoshio
    Komuro, Issei
    Takano, Hiroyuki
    [J]. CIRCULATION JOURNAL, 2012, 76 (05) : 1159 - 1168